ROCHE DIAGNOSTICS BELGIUM
ActiveSummary
ROCHE DIAGNOSTICS BELGIUM has been active since 1958 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.2m and a net result of €1.2m. Equity has been growing by about 11% per year since 2018. Its solvency ranks better than 63% of 6,172 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 07-11-1958 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Joint committee
- 207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2025
- Establishment unit
- 2.005.770.255 1831 Machelen (Brab.), since 01-11-1958
- Financial year end
- 31 December
- Peppol
- Reachable since 11-11-2025
Board and ownership
- Lisandro ZarateManaging director
- Maria BorstDirector · since 01-07-2022
- Esther de RooijDirector
- Auditor
- KPMG Bedrijfsrevisoren BV/SRL
- Roche Finanz AG99.99%annual accounts 2025
- ROCHE HOLDING AGconsolidatesannual accounts 2025
- Roche Pharmholding BV0.01%annual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Turnover
- €131.2m
- ▲ 1.3%
- Profit
- €1.2m
- ▼ 38.7%
- Equity
- €36.2m
- ▲ 3.5%
- Total assets
- €64.0m
- ▲ 1.4%
- Employees on 31-12-2025
- 194
- ▲ 0.5%
Score breakdownraises riskLiquidity: current ratio 1.60, cash €0lowers riskSize: turnover €131.2m, 187.3 FTE, total assets €64.0mFounded in 1958Equity €36.2m (56.5% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized). It does better than 70% of them on solvency, 39% on liquidity, 72% on profitability and 46% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 27 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Board changedlatest change 01-10-2026 · 3 in office 3 joined · 3 left View
- Positive: More equity than 95% of companies in wholesale tradesector median €1.6m · 6,104 companies €36.2m View
- Positive: 8 profitable years in a rowprofit 2025: €1.2m 8 years View
- Caution: Result fell in 2025from €2.0m to €1.2m ▼ 38.7% View
- Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
Recent changes
- · Gazette deed Resignation: Isabelle Decker (managing director)Appointment: Lisandro Zarate (managing director)
- · Gazette deed Resignations: Bernard Colombo (director) and Maria Johanna Borst (director)Appointments: Esther de Rooij (director) and Silvia Barceleiro (director)
- · Gazette deed Reappointments: Bernard Colombo, Isabelle Decker and 2 others
Comparable companies
These companies have the same main activity as ROCHE DIAGNOSTICS BELGIUM: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €49m and €110m, founded between 1948 and 1975.
| Company | Total assets | Turnover |
|---|---|---|
| ROCHE DIAGNOSTICS BELGIUM Machelen (Brab.) | €64.0m | €131.2m |
| EUMEDICA Manage | €61.2m | €81.2m |
| MENARINI BENELUX Machelen (Brab.) | €48.6m | €78.3m |
| DRÄGER BELGIUM Wemmel | €52.1m | €61.9m |
| GlaxoSmithKline Pharmaceuticals Wavre | €58.2m | €241.2m |
| Medtronic Belgium Jette | €110.4m | €196.3m |
| S.A. NOVO NORDISK PHARMA N.V. Dilbeek | €67.2m | €197.1m |
Key facts about ROCHE DIAGNOSTICS BELGIUM
- What is the company number of ROCHE DIAGNOSTICS BELGIUM?
- The company number of ROCHE DIAGNOSTICS BELGIUM is 0403.049.945. The VAT number is the same number with BE in front: BE 0403.049.945.
- Where is ROCHE DIAGNOSTICS BELGIUM based?
- The registered office is at Berkenlaan 8A, 1831 Machelen (Brab.).Company details
- What does ROCHE DIAGNOSTICS BELGIUM do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of ROCHE DIAGNOSTICS BELGIUM?
- The legal form of ROCHE DIAGNOSTICS BELGIUM is Public limited company (NV).
- When was ROCHE DIAGNOSTICS BELGIUM founded?
- ROCHE DIAGNOSTICS BELGIUM was founded on 07-11-1958.
- Is ROCHE DIAGNOSTICS BELGIUM still active?
- Yes, ROCHE DIAGNOSTICS BELGIUM is an active enterprise in the KBO register.
- How many employees does ROCHE DIAGNOSTICS BELGIUM have?
- ROCHE DIAGNOSTICS BELGIUM had an average of 187.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ROCHE DIAGNOSTICS BELGIUM fall under?
- In its 2025 annual accounts, ROCHE DIAGNOSTICS BELGIUM states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
- What is the turnover of ROCHE DIAGNOSTICS BELGIUM?
- The turnover of ROCHE DIAGNOSTICS BELGIUM was €131.2m in financial year 2025, according to the filed annual accounts.
- Is ROCHE DIAGNOSTICS BELGIUM profitable?
- In financial year 2025, ROCHE DIAGNOSTICS BELGIUM made a profit of €1.2m.
- Where can I find the annual accounts of ROCHE DIAGNOSTICS BELGIUM?
- ROCHE DIAGNOSTICS BELGIUM filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ROCHE DIAGNOSTICS BELGIUM due?
- ROCHE DIAGNOSTICS BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.